We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Prospective Cross-Sectional Study of Acute Coronary Syndrome Patients' Quality of Life and Drug Prescription Patterns at Riyadh Region Hospitals, Saudi Arabia.
- Authors
Balaha, Mohamed F.; Alamer, Ahmed A.; Kabel, Ahmed M.; Aldosari, Saad A.; Fatani, Sarah
- Abstract
Acute coronary syndrome (ACS) is a leading cause of cardiovascular-related morbidity and mortality worldwide. The present study investigated the health-related quality of life (HRQOL) and drug prescribing patterns in ACS patients at Riyadh hospitals in Saudi Arabia. This study was a 12-month prospective cross-sectional study that included 356 patients with ACS. The current study showed that younger male (67.42%) and urban (75.84%) patients suffered more from ACS. Moreover, most patients with NSTEMI (51.69%) experienced Grade 1 dyspnea (33.43%) and NYHA Stage 2 (29.80%); however, STEMI patients were at greater mortality risk. The HRQOL questionnaire showed that ACS patients were significantly impaired in all QOL domains (emotional [23.0%, p = 0.001], physical [24.4%, p = 0.003], and social [27.2%, p = 0.002]). Furthermore, the most commonly prescribed medications were statins (93%), antiplatelets (84%), anticoagulants (79%), coronary vasodilators (65%), and beta-blockers (63%). Additionally, 64% of patients received PCIs or CABGs, with the majority of cases receiving PCIs (49%), whereas 9% received dual anticoagulant therapy. Thus, there is an urgent need to educate healthcare teams about the relevance of QOL in ACS control and prevention and the new ACS management recommendations. ACS is also growing among younger people, requiring greater attention and prevention.
- Subjects
SAUDI Arabia; STATINS (Cardiovascular agents); PERCUTANEOUS coronary intervention; CORONARY artery bypass; CROSS-sectional method; SYSTOLIC blood pressure; ACUTE coronary syndrome; HEALTH status indicators; ANTICOAGULANTS; CARDIOVASCULAR agents; DYSPNEA; ADRENERGIC beta blockers; ST elevation myocardial infarction; DIASTOLIC blood pressure; SOCIOECONOMIC factors; QUALITY of life; DRUG prescribing; PUBLIC hospitals; DRUGS; QUESTIONNAIRES; DESCRIPTIVE statistics; PLATELET aggregation inhibitors; VASODILATORS; RESEARCH funding; HEART beat; SCALE analysis (Psychology); PHYSICIAN practice patterns; METROPOLITAN areas; NON-ST elevated myocardial infarction; DATA analysis software; LONGITUDINAL method
- Publication
Healthcare (2227-9032), 2023, Vol 11, Issue 13, p1973
- ISSN
2227-9032
- Publication type
Article
- DOI
10.3390/healthcare11131973